6-Thioguanine damages mitochondrial DNA and causes mitochondrial dysfunction in human cells

Ilse Daehn1, Reto Brem, Eva Barkauskaite

  • 1Cancer Research UK London Research Institute, Clare Hall Laboratories, South Mimms, Herts, UK. ilse.daehn@mssm.edu

FEBS Letters
|November 9, 2011
PubMed

Insights

Thiopurines like 6-thioguanine (6-TG) accumulate in mitochondrial DNA (mtDNA), inhibiting its replication. Oxidized 6-TG in mtDNA, especially with UVA light, impairs mitochondrial function and contributes to cell death.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Thiopurines are anticancer and immunosuppressant drugs.
  • These drugs lead to the accumulation of 6-thioguanine (6-TG) in nuclear DNA.

Purpose of the Study:

  • To investigate the incorporation and effects of 6-TG in mitochondrial DNA (mtDNA).
  • To determine the role of mtDNA 6-TG in drug-induced cellular toxicity, particularly in combination with UVA radiation.

Main Methods:

  • Investigated 6-TG incorporation into mtDNA.
  • Assessed the impact of oxidized mtDNA 6-TG on DNA polymerase gamma (Pol-γ) activity.
  • Measured mtDNA transcription, mitochondrial protein levels, and mitochondrial function.
  • Examined the role of UVA radiation in oxidizing mtDNA 6-TG.
  • Compared the sensitivity of mtDNA-containing and mtDNA-depleted cells to 6-TG and UVA treatment.

Main Results:

  • 6-TG is incorporated into mtDNA and rapidly oxidized.
  • Oxidized mtDNA 6-TG inhibits DNA Pol-γ, reducing mtDNA replication.
  • Accumulation of oxidized 6-TG leads to decreased mtDNA transcription, lower mitochondrial protein levels, and impaired mitochondrial function.
  • UVA radiation promotes the oxidation of mtDNA 6-TG.
  • Cells lacking mtDNA are less sensitive to combined 6-TG and UVA treatment, suggesting mtDNA's role in photosensitization.

Conclusions:

  • Mitochondrial DNA is a target for 6-TG accumulation and oxidation.
  • Oxidized mtDNA 6-TG disrupts mitochondrial replication and function.
  • Mitochondrial 6-TG oxidation contributes to the photosensitizing effects of 6-TG combined with UVA radiation.

Related Concept Videos

Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mutations01:39

Mutations

Overview
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...